Business Standard

Dr Reddy's Lab settles blister package case in US for $5 mn

US Consumer Product Safety Commission(CPSC) has requested the US Department of Justice to impose civil penalty on Dr Reddy's

Dr Reddy's
Premium

B Dasarath Reddy Hyderabad
Indian drug major’s Laboratories Limited has reached a settlement with the US government agencies for $5 million in a six-year-old case regarding complaints of potential harm from the package of blister-packed prescription products to children.

In June last year, US Consumer Product Safety Commission(CPSC) has requested the US Department of Justice to impose civil penalty on Dr Reddy’s for alleged violations of provisions related to child-resistant packaging in at least five prescription drugs.

While disagreeing with these allegations, the company on Tuesday said it had chosen to settle the matter in order to avoid any unnecessary costs and the distractions of prolonged

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in